PF-5006739 is a potent and selective inhibitor of CK1δ/ε with IC50s of 3.9 nM and 17.0 nM, respectively. PF-5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1δ/ε and high kinome selectivity. PF-5006739 attenuats opioid agent-seeking behavior in a rodent operant reinstatement model in animals in a dose-dependent manner. PF-5006739 improves glucose tolerance in both diet-induced obesity (DIO) and genetic (ob/ob) mice models of obesity.
Specifications and Purity: ≥98%
Molecular Formula: C₂₂H₂₂FN₇O
Molecular Weight: 419.46
PubChem CID: 51353555
Isomeric SMILES: C1CN(CCC1N2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F)CC5=NOC=C5
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/P288881-SCI_c13a4e51c9d974c6551f2f14ec80df85.pdf
- UPC:
- 12141723
- Condition:
- New
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- P288881-10mg
- CAS:
- 1293395-67-1
- Health Hazards:
- Toxic
- Product Size:
- 10mg
- Hazard Statement Codes:
- H301
- Precautionary Statement Codes:
- P501:P405:P330:P321:P301:P270:P264
akash.verma@cenmed.com
(732) 447-1115





